Cargando…
Peripheral nervous system manifestations of Shiga toxin-producing E. coli-induced haemolytic uremic syndrome in children
BACKGROUND: The Neurological involvement is the most common extra-renal complication of Shiga toxin-producing E. coli-hemolytic uremic syndrome (HUS) or typical HUS. On brain magnetic resonance examination, main neurological signs encompass acute lesions of the basal ganglia and the white matter, wh...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422760/ https://www.ncbi.nlm.nih.gov/pubmed/34488831 http://dx.doi.org/10.1186/s13052-021-01133-1 |
_version_ | 1783749341143367680 |
---|---|
author | Santangelo, Luisa Netti, Giuseppe Stefano Torres, Diletta Domenica Piscopo, Giovanni Carbone, Vincenza Losito, Luciana Milella, Leonardo Lasorella, Maria Luigia Conti, Pasquale Gagliardi, Delio Chironna, Maria Spadaccino, Federica Bresin, Elena Trabacca, Antonio Ranieri, Elena Giordano, Mario |
author_facet | Santangelo, Luisa Netti, Giuseppe Stefano Torres, Diletta Domenica Piscopo, Giovanni Carbone, Vincenza Losito, Luciana Milella, Leonardo Lasorella, Maria Luigia Conti, Pasquale Gagliardi, Delio Chironna, Maria Spadaccino, Federica Bresin, Elena Trabacca, Antonio Ranieri, Elena Giordano, Mario |
author_sort | Santangelo, Luisa |
collection | PubMed |
description | BACKGROUND: The Neurological involvement is the most common extra-renal complication of Shiga toxin-producing E. coli-hemolytic uremic syndrome (HUS) or typical HUS. On brain magnetic resonance examination, main neurological signs encompass acute lesions of the basal ganglia and the white matter, which could usually regress after Eculizumab infusion. In contrast, peripheral nervous system (PNS) manifestations in typical HUS are very rare and, when occurring, they require a careful management of neurological sequelae and an intensive multidisciplinary neuro-rehabilitation program. CASE PRESENTATION: Here, we present two pediatric cases of severe and complicated typical HUS with PNS manifestations who required therapeutic treatment and an intensive multidisciplinary neuro-rehabilitation program. In both cases, PNS manifestations were followed by the recovery from typical HUS-related severe central neurological damage and manifested mainly with marked bilateral motor deficit and hyporeflexia/areflexia in the lower limbs. The peripheral polyneuropathy was treated with immunosuppressive therapy (methylprednisolone boluses, i.v. immunoglobulins, plasma exchange), followed by a prolonged intensive neuro-rehabilitation program. After 8 months of rehabilitation, both patients gained complete functional recovery. CONCLUSIONS: PNS manifestations during typical HUS are a rare event and potentially leading to severe disability. A timely clinical assessment is mandatory to set up a prompt therapeutic and rehabilitation program and to obtain a complete clinical and functional recovery. |
format | Online Article Text |
id | pubmed-8422760 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-84227602021-09-09 Peripheral nervous system manifestations of Shiga toxin-producing E. coli-induced haemolytic uremic syndrome in children Santangelo, Luisa Netti, Giuseppe Stefano Torres, Diletta Domenica Piscopo, Giovanni Carbone, Vincenza Losito, Luciana Milella, Leonardo Lasorella, Maria Luigia Conti, Pasquale Gagliardi, Delio Chironna, Maria Spadaccino, Federica Bresin, Elena Trabacca, Antonio Ranieri, Elena Giordano, Mario Ital J Pediatr Case Report BACKGROUND: The Neurological involvement is the most common extra-renal complication of Shiga toxin-producing E. coli-hemolytic uremic syndrome (HUS) or typical HUS. On brain magnetic resonance examination, main neurological signs encompass acute lesions of the basal ganglia and the white matter, which could usually regress after Eculizumab infusion. In contrast, peripheral nervous system (PNS) manifestations in typical HUS are very rare and, when occurring, they require a careful management of neurological sequelae and an intensive multidisciplinary neuro-rehabilitation program. CASE PRESENTATION: Here, we present two pediatric cases of severe and complicated typical HUS with PNS manifestations who required therapeutic treatment and an intensive multidisciplinary neuro-rehabilitation program. In both cases, PNS manifestations were followed by the recovery from typical HUS-related severe central neurological damage and manifested mainly with marked bilateral motor deficit and hyporeflexia/areflexia in the lower limbs. The peripheral polyneuropathy was treated with immunosuppressive therapy (methylprednisolone boluses, i.v. immunoglobulins, plasma exchange), followed by a prolonged intensive neuro-rehabilitation program. After 8 months of rehabilitation, both patients gained complete functional recovery. CONCLUSIONS: PNS manifestations during typical HUS are a rare event and potentially leading to severe disability. A timely clinical assessment is mandatory to set up a prompt therapeutic and rehabilitation program and to obtain a complete clinical and functional recovery. BioMed Central 2021-09-06 /pmc/articles/PMC8422760/ /pubmed/34488831 http://dx.doi.org/10.1186/s13052-021-01133-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Case Report Santangelo, Luisa Netti, Giuseppe Stefano Torres, Diletta Domenica Piscopo, Giovanni Carbone, Vincenza Losito, Luciana Milella, Leonardo Lasorella, Maria Luigia Conti, Pasquale Gagliardi, Delio Chironna, Maria Spadaccino, Federica Bresin, Elena Trabacca, Antonio Ranieri, Elena Giordano, Mario Peripheral nervous system manifestations of Shiga toxin-producing E. coli-induced haemolytic uremic syndrome in children |
title | Peripheral nervous system manifestations of Shiga toxin-producing E. coli-induced haemolytic uremic syndrome in children |
title_full | Peripheral nervous system manifestations of Shiga toxin-producing E. coli-induced haemolytic uremic syndrome in children |
title_fullStr | Peripheral nervous system manifestations of Shiga toxin-producing E. coli-induced haemolytic uremic syndrome in children |
title_full_unstemmed | Peripheral nervous system manifestations of Shiga toxin-producing E. coli-induced haemolytic uremic syndrome in children |
title_short | Peripheral nervous system manifestations of Shiga toxin-producing E. coli-induced haemolytic uremic syndrome in children |
title_sort | peripheral nervous system manifestations of shiga toxin-producing e. coli-induced haemolytic uremic syndrome in children |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422760/ https://www.ncbi.nlm.nih.gov/pubmed/34488831 http://dx.doi.org/10.1186/s13052-021-01133-1 |
work_keys_str_mv | AT santangeloluisa peripheralnervoussystemmanifestationsofshigatoxinproducingecoliinducedhaemolyticuremicsyndromeinchildren AT nettigiuseppestefano peripheralnervoussystemmanifestationsofshigatoxinproducingecoliinducedhaemolyticuremicsyndromeinchildren AT torresdilettadomenica peripheralnervoussystemmanifestationsofshigatoxinproducingecoliinducedhaemolyticuremicsyndromeinchildren AT piscopogiovanni peripheralnervoussystemmanifestationsofshigatoxinproducingecoliinducedhaemolyticuremicsyndromeinchildren AT carbonevincenza peripheralnervoussystemmanifestationsofshigatoxinproducingecoliinducedhaemolyticuremicsyndromeinchildren AT lositoluciana peripheralnervoussystemmanifestationsofshigatoxinproducingecoliinducedhaemolyticuremicsyndromeinchildren AT milellaleonardo peripheralnervoussystemmanifestationsofshigatoxinproducingecoliinducedhaemolyticuremicsyndromeinchildren AT lasorellamarialuigia peripheralnervoussystemmanifestationsofshigatoxinproducingecoliinducedhaemolyticuremicsyndromeinchildren AT contipasquale peripheralnervoussystemmanifestationsofshigatoxinproducingecoliinducedhaemolyticuremicsyndromeinchildren AT gagliardidelio peripheralnervoussystemmanifestationsofshigatoxinproducingecoliinducedhaemolyticuremicsyndromeinchildren AT chironnamaria peripheralnervoussystemmanifestationsofshigatoxinproducingecoliinducedhaemolyticuremicsyndromeinchildren AT spadaccinofederica peripheralnervoussystemmanifestationsofshigatoxinproducingecoliinducedhaemolyticuremicsyndromeinchildren AT bresinelena peripheralnervoussystemmanifestationsofshigatoxinproducingecoliinducedhaemolyticuremicsyndromeinchildren AT trabaccaantonio peripheralnervoussystemmanifestationsofshigatoxinproducingecoliinducedhaemolyticuremicsyndromeinchildren AT ranierielena peripheralnervoussystemmanifestationsofshigatoxinproducingecoliinducedhaemolyticuremicsyndromeinchildren AT giordanomario peripheralnervoussystemmanifestationsofshigatoxinproducingecoliinducedhaemolyticuremicsyndromeinchildren |